ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Takeda, Sosei form gastrointestinal disease R&D pact fiercepharma
August 13, 2019Takeda and Sosei Heptares have entered into a multitarget R&D?agreement. Sosei is set to receive $26 million (€23 million) in upfront and near-term payments, plus up to $1.2 billion in milestones, to apply its GPCR expertise to targets of interest to Take
Pharma Sources Insight January 2025
